84 related articles for article (PubMed ID: 7043339)
21. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
22. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
23. A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer.
Amadori D; Frassineti GL; Zoli W; Milandri C; Tienghi A; Ravaioli A; Gentile A; Salzano E
Semin Oncol; 1996 Oct; 23(5 Suppl 11):16-22. PubMed ID: 8893894
[TBL] [Abstract][Full Text] [Related]
24. Combined-modality therapy for esophageal cancer: phase I trial of escalating doses of paclitaxel in combination with cisplatin, 5-fluorouracil, and high-dose radiation before esophagectomy.
Weiner LM; Colarusso P; Goldberg M; Dresler C; Coia LR
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-93-S19-95. PubMed ID: 9427276
[TBL] [Abstract][Full Text] [Related]
25. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
[TBL] [Abstract][Full Text] [Related]
26. A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: preliminary results.
Hitt R; Hornedo J; Colomer R; Mendiola C; Brandariz A; Sevilla E; Alvarez-Vicent J; Cortés-Funes H
Semin Oncol; 1995 Dec; 22(6 Suppl 15):50-4. PubMed ID: 8643971
[TBL] [Abstract][Full Text] [Related]
27. Treatment of patients with upper gastrointestinal carcinomas.
Ajani JA
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-72-S19-76. PubMed ID: 9427271
[TBL] [Abstract][Full Text] [Related]
28. Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.
Shapiro JD; Rothenberg ML; Sarosy GA; Steinberg SM; Adamo DO; Reed E; Ozols RF; Kohn EC
Cancer; 1998 Nov; 83(9):1980-8. PubMed ID: 9806657
[TBL] [Abstract][Full Text] [Related]
29. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
[TBL] [Abstract][Full Text] [Related]
30. Intraperitoneal high-dose cisplatin and etoposide with systemic thiosulfate protection in second-line treatment of advanced ovarian cancer.
Malmström H; Rasmussen S; Simonsen E
Gynecol Oncol; 1993 May; 49(2):166-71. PubMed ID: 8504983
[TBL] [Abstract][Full Text] [Related]
31. Phase II trial of cisplatin in the treatment of patients with advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Orr JW; DiSaia PJ
Cancer Treat Rep; 1986 Feb; 70(2):271-4. PubMed ID: 3948191
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a southwest oncology group study.
Al-Sarraf M; Fletcher W; Oishi N; Pugh R; Hewlett JS; Balducci L; McCracken J; Padilla F
Cancer Treat Rep; 1982 Jan; 66(1):31-5. PubMed ID: 6796269
[TBL] [Abstract][Full Text] [Related]
33. Nonhormonal chemotherapy in endometrial cancer--a review.
Deppe G; Malviya VK; Zbella E
Wien Klin Wochenschr; 1984 Oct; 96(20):747-56. PubMed ID: 6441352
[TBL] [Abstract][Full Text] [Related]
34. Treatment of recurrent endometrial adenocarcinoma with a combination of doxorubicin and cisplatin.
Tropé C; Johnsson JE; Simonsen E; Christiansen H; Cavallin-Ståhl E; Horváth G
Am J Obstet Gynecol; 1984 Jun; 149(4):379-81. PubMed ID: 6539567
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study.
Thigpen JT; Blessing JA; Homesley H; Creasman WT; Sutton G
Gynecol Oncol; 1989 Apr; 33(1):68-70. PubMed ID: 2703169
[TBL] [Abstract][Full Text] [Related]
36. Phase II trial of cisplatin as second-line chemotherapy in patients with advanced or recurrent endometrial carcinoma. A Gynecologic Oncology Group study.
Thigpen JT; Blessing JA; Lagasse LD; DiSaia PJ; Homesley HD
Am J Clin Oncol; 1984 Jun; 7(3):253-6. PubMed ID: 6539565
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin therapy for disseminated mixed mesodermal sarcoma of the uterus.
Gershenson DM; Kavanagh JJ; Copeland LJ; Edwards CL; Stringer CA; Wharton JT
J Clin Oncol; 1987 Apr; 5(4):618-21. PubMed ID: 3559652
[TBL] [Abstract][Full Text] [Related]
38. [High-dose progesterone therapy in advanced endometrial cancer].
Lotze W; Richter P; Sarembe B
Arch Geschwulstforsch; 1982; 52(7):569-74. PubMed ID: 6187310
[TBL] [Abstract][Full Text] [Related]
39. Cisplatin. An active drug in the treatment of disseminated gastric cancer.
Leichman L; McDonald B; Dindogru A; Samson M; Vaitkevicius VK
Cancer; 1984 Jan; 53(1):18-22. PubMed ID: 6317158
[TBL] [Abstract][Full Text] [Related]
40. Cisplatin in the treatment of metastatic breast carcinoma: A prospective randomized trial of two dosage schedules.
Forastiere AA; Hakes TB; Wittes JT; Wittes RE
Am J Clin Oncol; 1982 Jun; 5(3):243-7. PubMed ID: 7044098
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]